Abiopharma

News list

Crook Nathaniel Glenn 🟢 acquired 1.3M shares of Amplitude, Inc. (AMPL) Transaction Date: Apr 15, 2026 | Filing ID: 000002

Full text

News bot April 17, 2026, 9:55 p.m.
🔍 Crook Nathaniel Glenn (Executive)

Company: Amplitude, Inc. (AMPL)

Report Date: 2026-04-15
Transaction Summary:
- Total transactions: 2
- Derivative instruments: 0
- Holdings reported: 0
- Total shares acquired: 1,253,481
Detailed Transactions and Holdings:
- Acquired 278,551 shares of Class A Common Stock (Direct)
  Date: 2026-04-15 | Code: A | equity_swap_involved: false | shares_owned_after: 1,156,096.00 | transaction_form_type: 4 | Footnotes: F1, F2
- Acquired 974,930 shares of Class A Common Stock (Direct)
  Date: 2026-04-15 | Code: A | equity_swap_involved: false | shares_owned_after: 2,131,026.00 | transaction_form_type: 4 | Footnotes: F3, F4
Footnotes:
- F1: Each restricted stock unit ("RSU") represents a right to receive one share of the Issuer's Class A Common Stock. The RSUs vest in four substantially equal quarterly installments beginning on May 15, 2026, subject to the continued service of the reporting person through each vesting date.
- F2: Includes 726,441 restricted stock units.
- F3: Each RSU represents a right to receive one share of the Issuer's Class A Common Stock. The RSUs vest in twelve substantially equal quarterly installments beginning on May 15, 2026, subject to the continued service of the reporting person through each vesting date.
- F4: Includes 1,701,371 RSUs.